Literature DB >> 3530470

Proarrhythmic responses during electrophysiologic testing.

A P Rae.   

Abstract

Proarrhythmia is a potentially lethal adverse effect of antiarrhythmic drugs. Underlying mechanisms and the approaches to identification are discussed. The applicability of electrophysiologic testing is considered, with particular reference to the validity of the different responses to programmed stimulation considered to be manifestations of proarrhythmia. The incidence of proarrhythmia in relation to individual antiarrhythmic agents is also reviewed.

Mesh:

Substances:

Year:  1986        PMID: 3530470

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.

Authors:  M Sedgwick; H S Rasmussen; D Walker; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

Review 2.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

3.  A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

Authors:  L J Jordaens; F Colardyn; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.